Status | Study |
Active, not recruiting |
Study Name: Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2014-10-30 Interventions: Drug: eteplirsen Eteplirsen 30 mg/kg will be administered as an IV infusion once a week for up to 144 we |
Completed |
Study Name: Stem Cell Therapy in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2014-09-12 Interventions: Biological: Stem Cell Intrathecal autologous bone marrow mononuclear cell transplantation |
Recruiting |
Study Name: Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2014-07-17 Interventions: Other: Magnetic Resonance Imaging (MRI) |
Active, not recruiting |
Study Name: Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2013-08-01 Interventions: Drug: NPC-14 |
Terminated |
Study Name: A Study of Tadalafil for Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2013-05-24 Interventions: Drug: Tadalafil Administered o |
Withdrawn |
Study Name: Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2012-05-21 Interventions: Biological: human umbilical cord mesenchymal stem cells rehabilitation therapy plus human umbilical cord |
Recruiting |
Study Name: Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy Condition: Muscular Dystrophy, Duchenne Date: 2011-12-22 |
Completed |
Study Name: Safety Study of Flavocoxid in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2011-04-12 Interventions: Drug: Flavocoxid Flavocoxid capsules TTD 500 mg/die or 1000 mg/die for 1 year |
Active, not recruiting |
Study Name: Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy Condition: Duchenne Muscular Dystrophy Date: 2010-08-17 Interventions: Drug: Epigallocatechin-Gallate |
Completed |
Study Name: Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD) Condition: Muscular Dystrophy, Duchenne Ambulatory Care Date: 2009-12-08 Interventions: Drug: Placebo Placebo (900 mg/ |